Psilocybin
Top View
- PSILOCIN PSILOCYBIN Latest Revision: June 27, 2005
- Legal Status of Psychedelic Drugs and Research Involving Possible Medical Uses
- 2019 National Survey on Drug Use and Health: Detailed
- The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations
- The Therapeutic Potential of Psilocybin
- Analysis of Psilocybin and Psilocin in Psilocybe ´ Subcubensis GUZMAN by Ion Mobility Spectrometry and Gas Chromatography–Mas
- Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances NEPTUNE
- Magic Mushrooms Is Reported
- Signaling Mechanism Responsible for 5-HT2A Receptor Tolerance to Psychedelic Induced Head-Twitch Behavior in Mice
- Psychedelic Support a Practical Guide to Establishing and Facilitating Care Services at Music Festivals and Other Events
- Overview of the Major Classes of New Psychoactive Substances
- Clinical Trials of Psilocybin and Ecstasy As Treatments for Depression And
- Psychedelics, Trauma & Addiction
- Psychedelics Revamped Effect on Mortality12
- Metabolism of Psilocybin and Psilocin: Clinical and Forensic Toxicological Relevance
- Psilocybin Mushrooms Are Found in Mexico, Central America, and the United States
- Alpha-Methyltryptamine (AMT)
- The Utility of Psilocybin in Managing Anxiety and Depression in Cancer Patients